Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With Lux Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - Clinical SafetY and Effectiveness

NCT07454980 is registered in ClinicalTrials.gov with Jenscare Innovation Inc. as lead sponsor.

NCT NCT07454980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07454980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With Lux Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - Clinical SafetY and Effectiveness
Lead sponsor
Jenscare Innovation Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 15, 2026
Completion date
December 31, 2038
Enrollment
680 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation (tr)